Clinical trials
Completed Phase 1 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
2,263 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 9 |
| 2008 | 12 |
| 2009 | 20 |
| 2010 | 30 |
| 2011 | 34 |
| 2012 | 46 |
| 2013 | 36 |
| 2014 | 46 |
| 2015 | 54 |
| 2016 | 92 |
| 2017 | 95 |
| 2018 | 142 |
| 2019 | 194 |
| 2020 | 217 |
| 2021 | 276 |
| 2022 | 240 |
| 2023 | 289 |
| 2024 | 240 |
| 2025 | 141 |
| 2026 | 36 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2,263 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 162 |
| Innovent Biologics (Suzhou) Co. Ltd. | 51 |
| Sunshine Lake Pharma Co., Ltd. | 48 |
| Pfizer | 37 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 32 |
| GlaxoSmithKline | 30 |
| Shandong Suncadia Medicine Co., Ltd. | 27 |
| AstraZeneca | 26 |
| Haisco Pharmaceutical Group Co., Ltd. | 25 |
| The Affiliated Hospital of Qingdao University | 25 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 86 |
| Breast Neoplasms | 48 |
| Neoplasms | 46 |
| Obesity | 46 |
| Overweight | 40 |
| COVID-19 | 33 |
| Carcinoma, Non-Small-Cell Lung | 32 |
| Diabetes Mellitus | 29 |
| Hepatitis B, Chronic | 25 |
| Arthritis, Rheumatoid | 21 |
Trials
Showing 1 to 25 of 2,263. Each trial links to its page on Pharma Observatory.
2,163 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.